taisho pharmaceutical holdin
(4581:Tokyo Stock Exchange)
MD & Executive Director,Taisho Pharmaceutical Holdings Co., Ltd.
|Age||Total Calculated Compensation||This person is connected to 23 board members in 2 different organizations across 2 different industries.|
See Board Relationships
Mr. Ken Uehara has been Managing Director and Executive Director at Taisho Pharmaceutical Holdings Co., Ltd. since October 2011 and June 2013 repectively. Mr. Uehara serves as Executive Vice President and Director at Taisho Pharmaceutical Co., Ltd. and served as its Managing Director.
3-24-1, TakadaPhone: 81 3 3985 2020
Tokyo, -- 170-8655
Board Members Memberships*
Executive Vice President and Director
MD & Executive Director
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|Nick A. Caporella||Chairman of the Board & CEO|
National Beverage Corp.
|Alison Mary Watkins BCom, FCA, SF Fin, FAICD||Group Managing Director and Executive Director|
Coca-Cola Amatil Limited
|Manoj Kumar||MD & Director|
GlaxoSmithKline Consumer Healthcare Limited
|Jae-Hyuk Lee||CEO & Vice Chairman |
Lotte Chilsung Beverage Co.,Ltd.
|Larry D. Young||CEO, President & Executive Director|
Dr Pepper Snapple Group, Inc.
|$1.1M||Compensation as of Fiscal Year 2017.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.